Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 94 | SFEBES2023 | Next issue

Society for Endocrinology BES 2023

Glasgow, UK
13 Nov 2023 - 15 Nov 2023

Card image cap
SfE BES is the UK's leading endocrinology meeting. It will return to Glasgow in 2023.

Nurse Sessions

Primary Hyperparathyroidism: diagnosis to treatment

ea0094ns1.1 | Primary Hyperparathyroidism: diagnosis to treatment | SFEBES2023

Primary Hyperparathyroidism: Can innovative technologies improve current diagnostic and therapeutic pathways?

Kurzawinski Tom

Primary Hyperparathyroidism (PHPT) is, after diabetes and thyroid diseases, the third commonest endocrine disorder and its incidence and prevalence is rising globally. In the United Kingdom, the incidence of PHPT has been estimated to be 25/100,000, and prevalence has risen from 1.8 to 6.7 per 1000 between 1997-2006, implying that in the UK alone, about half a million people suffer from this condition and 12.000 develop it each year. Recognition of increased PHPT related morbi...

ea0094ns1.3 | Primary Hyperparathyroidism: diagnosis to treatment | SFEBES2023

Parathyroid UK and the Patient Perspective

Fryer Caroline

Parathyroid UK is a national patient organisation committed to improving the quality of life for everyone with parathyroid disorders. We provide information and support to empower our 5,000 members affected by a parathyroid condition to become active in the management of their condition. In Primary Hyperparathyroidism too much parathyroid hormone is produced by one or more enlarged or overactive parathyroid glands, causing hypercalcaemia. This impairs quality of life and incre...